EXPRESSION OF INTEREST FORM
MAPS Pillar 2: Support for Nigerian pharmaceutical manufacturers towards WHO
prequalification
Please complete every section and send the form with the five documents listed in
section 4 of the call by Tuesday, November 17, 2026, 17:00 WAT. Short answers are enough; detailed
documents are only requested from shortlisted manufacturers. Information is treated as confidential and is not
shared with regulators without your written consent (see section 7 of the call).
Fields marked with * are required.
A. Company details
B. Regulatory standing
C. Candidate products
Please list up to three candidate products in order of priority. Product 1 is required.
Product 1 – Priority product
Product 2 – Optional
Product 3 – Optional
D. Facility and quality systems
Tick the answer that best describes the current position. “In progress” is a perfectly
acceptable answer; the purpose of MAPS support is to help close gaps.
| Item |
Status |
| Current Site Master File * |
|
| Written quality system covering deviations, CAPA, change control and out-of-specification results * |
|
| Validation master plan, with process and cleaning validation * |
|
| Dedicated air handling units serving production areas * |
|
| Sterile (Grade A/B) area, if a candidate product is an injectable * |
|
| Purified water system with routine monitoring * |
|
| Separate chemical and microbiology quality control laboratories * |
|
| High-performance liquid chromatography (HPLC) and dissolution testing equipment * |
|
| Stability chambers for Zone IVb conditions (30°C / 75% relative humidity) * |
|
| Electronic audit trails and controlled user access on laboratory systems * |
|
| Backup power for production areas, laboratories and stability chambers * |
|
E. Market and impact
F. Other support received
G. Readiness to co-finance
H. Declaration
Document checklist
Please upload the following supporting documents.